Ninlaro Capsule
Product Images NDC 63020-400

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ninlaro (NDC 63020-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ninlaro 01)

Chemical structure of ixazomib, the active ingredient in NINLARO capsules, showing the molecular arrangement including chlorine atoms, boron, carbonyl groups, and carboxylic acid functionalities.*

FDA Label Image

Figure 1 (Ninlaro 02)

A Kaplan-Meier survival curve chart comparing the probability of progression-free survival over time (in months) between two groups: a placebo regimen and an ixazomib regimen. The graph shows distinct curves for each group with censored data points marked. The number of patients at risk across different months is displayed below the x-axis.*

FDA Label Image

Principal Display Panel (4 mg Capsule Blister Pack)

Packaging label for NINLARO (ixazomib) capsules with a strength of 4 mg per capsule. The label includes instructions to press and hold a button to pull out the medication card. The labeler is Takeda Pharmaceuticals America, Inc. The box is primarily white with orange and blue sections, and displays the Takeda logo.*

FDA Label Image

Principal Display Panel (3 mg Capsule Blister Pack)

NINLARO (ixazomib) capsules label for 3 mg strength. The label includes the product name, active ingredient, dosage form as capsules, and strength of 3 mg per capsule. It shows instructions to press and hold to pull out the medication card and states the package contains 1 capsule. The manufacturer is Takeda Pharmaceuticals America, Inc. The label features a barcode and NDC 63020-390-01.*

FDA Label Image

Principal Display Panel (2.3 mg Capsule Blister Pack)

Packaging label for NINLARO (ixazomib) capsules, 2.3 mg per capsule, by Takeda Pharmaceuticals America, Inc. The label includes instructions to press and hold a button to pull out the medication card and states the package contains 1 capsule. The label also shows the NDC number 63020-230-01 and features the Takeda logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.